Patent: 9,493,524
✉ Email this page to a colleague
Summary for Patent: 9,493,524
Title: | Methods for treatment of stroke or cerebrovascular accidents using an ET.sub.B receptor agonist |
Abstract: | Methods of using an ET.sub.B receptor agonist, such as IRL-1620, for the treatment of stroke or cerebrovascular accidents are disclosed. The ET.sub.B receptor agonist is used alone or in combination with a second agent useful in the treatment of stroke or other cerebrovascular accident. |
Inventor(s): | Gulati; Anil (Naperville, IL) |
Assignee: | MIDWESTERN UNIVERSITY (Downers Grove, IL) |
Application Number: | 14/149,785 |
Patent Claims: | see list of patent claims |
Details for Patent 9,493,524
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | 06/01/1989 | ⤷ Try a Trial | 2027-08-21 |
Amgen, Inc. | EPOGEN/PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2027-08-21 | |
Amgen, Inc. | PROCRIT | epoetin alfa | Injection | 103234 | ⤷ Try a Trial | 2027-08-21 | |
Genentech, Inc. | TNKASE | tenecteplase | For Injection | 103909 | 06/02/2000 | ⤷ Try a Trial | 2027-08-21 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |